Shares of the largest U.S. drugstore chain rose 2.8% to $36.93.
The company said it expects strong adjusted profit growth in the
second half of 2021, as impact of the COVID-19 pandemic
subsides, and supported by its recovery plans.
Last quarter, the company suffered a significant decline in
footfall in its UK-based retail pharmacies, and resorted to
store closures, job cuts and suspension of share repurchases.
Same-store sales at the company's retail pharmacy division in
the United States rose 3.6% from a year earlier.
Excluding items, Walgreens earned $1.02 per share, beating
analysts' expectations of 96 cents per share.
(Reporting By Manas Mishra and Mrinalika Roy in Bengaluru;
Editing by Vinay Dwivedi)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|